FDA Drugs recall ·
GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG… recall
- Recall number
- D-0587-2026
- Date
- (initiated May 29, 2026)
- Company / brand
- Golden State Medical Supply Inc.
5187 Camino Ruiz, Camarillo, CA, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 2,961 bottles
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90.
Why was it recalled?
Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lots: GS065128, GS065844, GS066695, GS067432, GS067993, expires: 01/31/2027.
Distribution
Within the U.S Market.
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0587-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.